Status: In Virginia, qualified patients may possess and use CBD extracts. State licensed pharmacuetical processors may cultivate, process, and dispense the CBD extracts to patients.
|CBD Program||Medical Program||Recreational Program||Are Applications Open?|
|Legal||Not legal||Not legal||closed|
Number of Virginia Licenses Available
Virginia Medical Marijuana Processor Guidelines
A Pharmaceutical Processor license is required to operate a facility that cultivates Cannabis plants intended only for the production of cannabidiol oil or THC-A oil, produces cannabidiol oil or THC-A oil, and dispenses cannabidiol oil or THC-A oil to a registered patient or, if such patient is a minor or an incapacitated adult as defined in § 18.2-369, such patient’s parent or legal guardian.
- A pharmaceutical processor shall dispense only cannabidiol oil and THC-A oil that has been cultivated and produced on the premises of such pharmaceutical processor.
- A non-refundable application fee of $10,000 is due at the time of application submission.
- An initial permit fee of $60,000 is due prior to the issuance of the permit.
- The permit is valid for one year and may be renewed annually pursuant to Board regulations for continued operation
REQUIRED VIRGINIA MARIJUANA BUSINESS PLANS FOR PHARMACEUTICAL PROCESSOR LICENSE:
- Virginia Marijuana Business Plan Package
- Business & Operations Plan Template
- Cultivation Plan Template
- Manufacturing/Processing Plan Template
- Environmental Plan Template
- Financial Plan Template
- Fire Safety Plan Template
- Inventory Control Plan Template
- Patient Education Plan Template
- Patient Recordkeeping Plan Template
- Product Safety Plan Template
- Security Plan Template
- Staffing Plan Template
- Suitability of Proposed Plan Template
- Transportation Plan Template
The History of Virginia Marijuana
On March 16, 2017, Virginia Gov. Terry McAuliffe passed a law that allowed patients suffering from intractable epilepsy access to cannabidiol (CBD) or THC-A oil. These oils have been shown to reduce the frequency and severity of seizures.
On March 9, 2018 the Governor signed House Bill 1251 into law to expand the state’s current medical marijuana program and allow the use of cannabidiol (CBD) or THC-A oil for the treatment of any diagnosed condition or disease determined by a practitioner, instead of limiting the qualifying conditions to only intractable epilepsy. Patients may enroll in the program with the state Board of Pharmacy with their physician’s authorization.
The Virginia Board of Pharmacy accepted applications for Pharmaceutical Processor Licenses until June 8, 2018. Out of 51 applicants, the five companies chosen include three established out-of-state businesses and two new Virginia-based entrepreneurs. The five companies are: PharmaCann Virginia, Dalitso, Dharma Pharmaceuticals, Green Leaf Medical of Virginia, and Columbia Care.